Strategy
ENGLISH DEUTSCH
WILEX at a glance
- Balanced portfolio of cancer therapeutic and diagnostic candidates from preclinical
to Phase III - Discovery, development, regulatory and commercial acumen
- Strong partnerships
- Multiple value inflexion points expected
Strategic goals
- Transition from a research driven company into a commercially driven organisation
- Development of the product candidates to marketability
- Financing of research and development programmes from operating cash flow








